BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT)
J. Waldron et al., BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT), Blood, 90(10), 1997, pp. 394-394